Who owns Legend Biotech Corp?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of LEGN from SEC Form 13F filings across 219 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 219 institutions disclosed 103.1M shares of Legend Biotech Corp worth $2.98B — about 55.1% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
219
13F holders
$2.98B
value, 2026 filers
55.1%
of shares outstanding (103.1M sh)
58
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of LEGN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 29.1M | $840.2M | 0.0% | 15.6% | +13.2% |
| 2 | DEERFIELD MANAGEMENT COMPANY, L.P. | 8.1M | $235.0M | 2.5% | 4.4% | +5.9% |
| 3 | MONTANOVA CAPITAL, LLC | 7.1M | $204.2M | 3.7% | 3.8% | -6.7% |
| 4 | HHLR ADVISORS, LTD. | 6.0M | $172.8M | 20.8% | 3.2% | 0.0% |
| 5 | BlackRock, Inc. | 4.7M | $136.5M | 0.0% | 2.5% | +0.9% |
| 6 | WESTFIELD CAPITAL MANAGEMENT CO LP | 4.4M | $127.9M | 0.4% | 2.4% | -23.1% |
| 7 | GOLDMAN SACHS GROUP INC | 3.7M | $105.8M | 0.0% | 2% | +150.1% |
| 8 | Point72 Asset Management, L.P. | 3.1M | $88.8M | 0.1% | 1.6% | -20.8% |
| 9 | Kynam Capital Management, LP | 3.0M | $86.7M | 4.8% | 1.6% | +90.4% |
| 10 | Assenagon Asset Management S.A.NEW | 1.9M | $55.3M | 0.1% | 1% | new |
| 11 | Artisan Partners Limited Partnership | 1.6M | $45.0M | 0.1% | 0.8% | -30.8% |
| 12 | STATE STREET CORP | 1.5M | $43.3M | 0.0% | 0.8% | 0.0% |
| 13 | Capital International Investors | 1.4M | $41.0M | 0.0% | 0.8% | +119.3% |
| 14 | MORGAN STANLEY | 1.4M | $40.3M | 0.0% | 0.7% | +131.2% |
| 15 | Soleus Capital Management, L.P.NEW | 1.2M | $34.8M | 1.2% | 0.6% | new |
| 16 | Davern Capital Partners, LP | 1.2M | $34.4M | 5.9% | 0.6% | -9.4% |
| 17 | Driehaus Capital Management LLCNEW | 1.2M | $33.5M | 0.2% | 0.6% | new |
| 18 | RENAISSANCE TECHNOLOGIES LLC | 1.0M | $28.9M | 0.0% | 0.5% | +91.7% |
| 19 | Ghisallo Capital Management LLCNEW | 1.0M | $28.9M | 0.6% | 0.5% | new |
| 20 | MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 917,266 | $26.5M | 9.1% | 0.5% | -0.9% |
| 21 | JOHNSON & JOHNSON | 814,586 | $23.5M | 2.9% | 0.4% | 0.0% |
| 22 | IvyRock Asset Management (HK) Ltd | 801,000 | $23.1M | 13.1% | 0.4% | -0.4% |
| 23 | EcoR1 Capital, LLCNEW | 800,000 | $23.1M | 1.1% | 0.4% | new |
| 24 | Squarepoint Ops LLC | 769,252 | $22.2M | 0.0% | 0.4% | +60.4% |
| 25 | JPMORGAN CHASE & CO | 766,364 | $22.5M | 0.0% | 0.4% | +166.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.